Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lixisenatide and Basal Insulin in T2DM (LixiBIT)
NCT02168491Phase 3Completed
- Sponsor
- Medical University of Vienna
- Start
- Nov 2014
- Primary completion
- Jul 2015
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of lixisenatide in type 2 diabetes mellitus (T2DM), sponsored by Medical University of Vienna. Started Nov 2014; status: completed.
02
Drugs
lixisenatide
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02168491.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02168491.